NEW STUDIES 1
The Kyolic Garlic & Aerobic Fitness Trial
Arterial stiffness is a cardiovascular risk factor, which increases naturally with age. Kyolic garlic has been shown to improve the flexibility of arteries, and slows down blood flow, which may improve oxygen uptake, associated with aerobic fitness.
NEW STUDIES 2
Trial Updates
September 2014:
We have now completed the trial! Many thanks to all participants & practitioners supporting this study. We have begun analysing the data, and have mailed participants their individual results. We plan to send out a final report to all those involved later in the year. We will also write up the findings for publication in the peer-reviewed literature. If you have any questions re the trial, please get in touch with the Principal Investigator Dr Karin Ried or Trial Research Assistant Nikolaj Travica.
June 2014:
We have now enrolled our 100th participant and are no longer recruiting for the trial. Thank you to all participants, clinics, and pharmacies supporting the trial, including the Hampton & South Medical Centre with Dr Michael Daly, and Alex Pala, pharmacist at the Priceline Pharmacy Pinewood in Mount Waverly. Data collection will continue until the end of August 2014. We will keep you updated with progress and results. If you have any questions re the trial, please get in touch with the Principal Investigator Dr Karin Ried or Trial Research Assistant Nikolaj Travica.
March 2014:
We have now enrolled our 60th participant! Thank you to all participants and the new clinics supporting the trial, including the Vermont South Health Care Clinic with Dr Jigau, and the North Yarra Community Centre with Dr Enkelmann. We are still recruiting, and are seeking 40 more participants. If you wish to support the trial, please get in touch with the Principal Investigator Dr Karin Ried.
Dec 2013:
28 patients with high blood pressure were enrolled in September 2013 and have now finished the 3-month trial. We will continue with enrolments from early January 2014. Any questions, contact Dr Karin Ried or Trial Nurse Adela Cretoiu.
Sept 2013:
This month NIIM has enrolled its 28th patient into the AGE at Heart trial. We would like to express our gratitude to the clinics and doctors who have been supporting the AGE at Heart trial, in particular The Medical Clinic in Glenferrie Rd with Dr Teperman, Dr Preston and Dr Luxton; the Distinct Health Care Clinic in Dandenong with Dr Jigau, and the NIIM clinic with Prof Sali, Dr Dagley, Dr Augustat, and the Wellbeing Clinic in Ashburton with Dr Holsman.
The AGE at Heart trial is investigating the effect of a garlic supplement on blood pressure, cholesterol, and other heart health markers.
The trial is taking place at the NIIM clinical trial centre in Hawthorn, Melbourne, in 2013 and 2014.
We are seeking adults
You can participate whether or not you are already taking blood pressure medication. It is important, however, that you are not planning to change any current BP treatment during the trial.
Participants receive
The AGE at Heart trial is registered with the Australian New Zealand Clinical Trial Registry and has received HREC ethics approval.
contact information
For more Information
https://niim-rebuild.newpathstudio.com.au/researches/nutritional-medicine/
The Importance of Social Connection
Social connection is essential to our health, well-being, and long-term survival.
Is Your Thyroid Causing Your Symptoms?
Thyroid disorders, especially hypothyroidism (underactive thyroid), are fairly common, impacting up to 10% of an older adult population, with the stats showing an estimated further 3.6% undiagnosed (Empson, Flood, Ma, Eastman, & Mitchell, 2007).
Clinical trial on the effect of cocoa on cognitive function
NIIM is conducting a clinical trial on the effect of cocoa on cognitive function in people aged 50 years or over.
External breast prosthesis (orthotics)
This study examined the effects of an external prosthesis on the reduction of load and discomfort/ pain through the chest of participants with augmented breasts.
Circulating Tumour Cells (CTC) Study
This observational CTC study uses the ISET® system to detect Circulating Tumour Cells (CTC) and other rare cells in the blood. Screening for CTCs can assist in early diagnosis of potential malignancy.
